1. Home
  2. COMP vs GKOS Comparison

COMP vs GKOS Comparison

Compare COMP & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COMP
  • GKOS
  • Stock Information
  • Founded
  • COMP 2012
  • GKOS 1998
  • Country
  • COMP United States
  • GKOS United States
  • Employees
  • COMP N/A
  • GKOS 995
  • Industry
  • COMP EDP Services
  • GKOS Medical/Dental Instruments
  • Sector
  • COMP Technology
  • GKOS Health Care
  • Exchange
  • COMP Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • COMP 4.3B
  • GKOS 5.1B
  • IPO Year
  • COMP 2021
  • GKOS 2015
  • Fundamental
  • Price
  • COMP $7.29
  • GKOS $90.26
  • Analyst Decision
  • COMP Buy
  • GKOS Strong Buy
  • Analyst Count
  • COMP 6
  • GKOS 13
  • Target Price
  • COMP $10.75
  • GKOS $155.00
  • AVG Volume (30 Days)
  • COMP 7.7M
  • GKOS 1.0M
  • Earning Date
  • COMP 05-07-2025
  • GKOS 04-30-2025
  • Dividend Yield
  • COMP N/A
  • GKOS N/A
  • EPS Growth
  • COMP N/A
  • GKOS N/A
  • EPS
  • COMP N/A
  • GKOS N/A
  • Revenue
  • COMP $5,629,100,000.00
  • GKOS $383,481,000.00
  • Revenue This Year
  • COMP $28.62
  • GKOS $27.84
  • Revenue Next Year
  • COMP $13.58
  • GKOS $27.99
  • P/E Ratio
  • COMP N/A
  • GKOS N/A
  • Revenue Growth
  • COMP 15.23
  • GKOS 21.85
  • 52 Week Low
  • COMP $3.03
  • GKOS $77.91
  • 52 Week High
  • COMP $10.25
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • COMP 35.57
  • GKOS 41.57
  • Support Level
  • COMP $7.04
  • GKOS $86.16
  • Resistance Level
  • COMP $7.91
  • GKOS $94.55
  • Average True Range (ATR)
  • COMP 0.56
  • GKOS 6.54
  • MACD
  • COMP -0.13
  • GKOS 1.11
  • Stochastic Oscillator
  • COMP 12.47
  • GKOS 54.51

About COMP Compass Inc.

Compass Inc provides an end-to-end platform that empowers residential real estate agents to deliver exceptional service to seller and buyer clients. The platform includes an integrated suite of cloud-based software for customer relationship management, marketing, client service and other critical functionality, all custom-built for the real estate industry and enabling core brokerage services. Business operations are conducted in the United States and earn revenue domestically.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: